ANI Pharmaceuticals entered a new three-year senior secured asset-based revolving credit facility for up to $30 million with Citizens Bank. This facility will be secured by inventory and certain other working capital and related assets of ANI Pharmaceuticals.

Arthur S. Przybyl, ANI’s president and CEO said, “Establishing a line of credit is an important milestone for ANI and one we view as appropriate given our company’s recent growth and future plans. We are excited to enter this financial partnership with Citizens Bank.”

“ANI Pharmaceuticals is a great new client and Citizens is very happy to combine our industry and asset-based financing expertise to help them achieve their strategic and financial goals,” said Chris Carmosino, head of asset-based finance at Citizens Bank.

ANI Pharmaceuticals is an integrated specialty pharmaceutical company developing, manufacturing, and marketing branded and generic prescription pharmaceuticals.